Therefore, we have compared the protein levels of IκB-α in the cytoplasm of peripheral blood cells from MS patients and healthy individuals, the NF-κB DNA binding potential of nuclear and whole cell lysates from MS patients and healthy controls and finally have compared the levels of activation of IKKα and IKKβ. This evidence concerns the gene NFKB1 and myeloid sarcoma.